

The Obesity Surgery Device market is experiencing significant growth, driven by rising obesity rates and increasing awareness of surgical options. As of 2023, the market size is estimated to exceed $4 billion, with advancements in technology and favorable reimbursement policies further enhancing adoption and driving innovation in surgical solutions. Request Sample Report
◍ Johnson & Johnson
◍ Medtronic
◍ Apollo Endosurgery
◍ Medtronic
◍ Mediflex Surgical Product
◍ Aspire Bariatrics
◍ Spatz FGIA
◍ MetaCure
◍ IntraPace
◍ TransEnterix
The obesity surgery device market features key players like Johnson & Johnson, Medtronic, and Apollo Endosurgery, focusing on innovative surgical technologies and minimally invasive solutions. These companies drive market growth through advanced product offerings, strategic partnerships, and expanding healthcare access. Sales revenues include:
- Johnson & Johnson: ~$93.77 billion
- Medtronic: ~$30.12 billion
- Apollo Endosurgery: ~$40 million.
Hospitals
Clinics ◍ Others
◍ Intragastric Balloons ◍ Gastric Electrical Stimulation ◍ Gastric Bands
Others
Request Sample Report
Request Sample Report
$ X Billion USD